Long a lobbying powerhouse in Washington, pharma’s struggling to settle on a strategy for defending itself, according to six industry lobbyists and three company officials who spoke to POLITICO. All ...

Big Pharma, long a lobbying powerhouse in Washington, is struggling to settle on a strategy for defending itself against ...

Ireland is an “outlier” in not opposing European Union reforms of the pharmaceutical industry that would potentially damage ...

The top 20 biopharmas demonstrated a strong start to 2025, despite ongoing uncertainty surrounding Trump’s tariffs.

Pharmacy benefit managers (PBMs) are up to bat in the perpetual blame game between PBMs and the pharmaceutical industry. | ...

Europe’s largest pharmaceutical companies are calling on the EU leadership to significantly increase the purchase and sales prices of ...

Major drugmakers were a standout on a tumultuous day of corporate earnings on Thursday, beating expectations even as they ...

Here’s what several large drugmakers said about tariffs when reporting earnings this morning: Merck made a small downward ...

Companies are announcing significant investments in U.S. manufacturing in response to looming tariffs. An AstraZeneca ...

Benchmark indices ended on a negative note with the Nifty 50 slipping below the 24,300 mark and the Sensex falling by ...

With potential tariffs and other drug pricing policies on the horizon, the industry is navigating uncertain waters. | The ...

Parcel giant UPS said on Thursday it would buy Canada's Andlauer Healthcare Group in an all-cash deal valued at $1.6 billion, ...